人工智能的临床研究中的差异使得从全球角度来看,AI的应用成为可能
Rui Yang1, Sabarinath Vinod Nair1, Yuhe Ke1,2
1Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.
NPJ digital medicine
|August 10, 2024
概括
医学中的人工智能 (AI) 由于全球差异而显示出有限的应用. 这项研究分析了人工智能临床研究中的地缘经济和性别不平等,强调需要公平地获得医疗人工智能技术.
科学领域:
- 医疗信息学 医疗信息学
- 健康 公平 卫生 公平
- 人工智能应用程序 人工智能应用程序
背景情况:
- 在医学上对人工智能 (AI) 有广泛的研究.
- 人工智能在临床环境中的实际实施仍然有限.
- 现有的人工智能支持的临床研究显示出全球显著的差异,影响健康公平.
研究的目的:
- 分析159个人工智能支持的临床研究的地缘经济分布.
- 在这些AI临床研究中调查性别差异.
- 突出医疗人工智能研究和开发中的全球不平等.
主要方法:
- 对包含159个人工智能支持的临床研究数据集的深入分析.
- 考察影响研究分布的地理和经济因素.
- 在分析的研究中评估性别代表性.
主要成果:
- 在人工智能支持的临床研究的分布中发现了显著的地缘经济差异.
- 在研究人员和这些研究的参与者中观察到性别不平衡.
- 调查结果显示,人工智能医学研究集中在特定的全球地区和人口统计数据中.
结论:
- 当前的人工智能临床研究格局反映了全球健康不平等.
- 解决地缘经济和性别差异对于医疗人工智能的公平发展至关重要.
- 促进对人工智能技术的包容性访问对于实现全球健康公平至关重要.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Current Trends in Nursing II
1.2K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
1.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Bias in Epidemiological Studies
190
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
190
Hazard Ratio
106
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
106


